Patterns of care for radiotherapy in vulvar cancer: A gynecologic cancer intergroup study

International Journal of Gynecological Cancer

Volumn 19, Issue 1, 2009, Pages 163-167

  Gaffney, David K ^a,m   Du Bois, Andreas ^b   Narayan, Kailash ^c   Reed, Nick ^d   Toita, Takafumi ^e   Pignata, Sandro ^b   Blake, Peter ^f   Portelance, Lorraine ^g   Sadoyze, Azmat ^h   Potter, Richard ^b   Colombo, Alessandro ⁱ   Randall, Marcus ^j   Mirza, Mansoor R ^k   Trimble, Edward L ^l  

^a Radiation Therapy Oncology Group   (Germany)

^b Arbeitsgemeinschaft Gynaekologische Onkologie ^*  (Australia)

^c Australia and New Zealand Gynecological Oncology Group   (Australia)

^d European Organization for Research   (Belgium)

^e Japanese Gynecologic Oncology Group   (Japan)

^f Royal Marsden Hospital   (United Kingdom)

^g Institut national du cancer du Canada   (Canada)

^h Scottish Gynaecological Cancer Trials Group   (United Kingdom)

ⁱ Mario Negri Gynecological Oncology Group   (Italy)

^j Gynecological Oncology Group   (United States)

^k Nordic Society of Gynecological Oncology   (Denmark)

^l NATIONAL CANCER INSTITUTE   (United States)

^m UNIVERSITY OF UTAH   (United States)

more..

Author keywords

Chemoradiation; Cooperative group; Vulva

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; MITOMYCIN; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; HEALTH CARE PLANNING; HEALTH SURVEY; HUMAN; INGUINAL REGION; LYMPH NODE METASTASIS; PATIENT CARE; PELVIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION FIELD; TREATMENT DURATION; TREATMENT INDICATION; VULVA CANCER; EPIDEMIOLOGY; FEMALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; RADIOTHERAPY; VULVA TUMOR;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HEALTH CARE SURVEYS; HUMANS; RADIOTHERAPY; VULVAR NEOPLASMS;

EID: 65649119647     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181996ac3     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2007;57(1):43-66.
2. Judson PL, Habermann EB, Baxter NN, et al. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006; 107(5):1018-1022.
3. Landrum LM, Lanneau GS, Skaggs VJ, et al. Gynecology Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era. Gynecol Oncol. 2007;106(3):521-525.
4. Beller U, Quinn MA, Benedet JL, et al. Carcinoma of the vulva. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet. 2006;95(Suppl 1):S7YS27.
5. Vermorken JB, Avall-Lundqvist E, Pfisterer J, et al. The Gynecologic Cancer Intergroup (GCIG): history and current status. Ann Oncol. 2005;16(Suppl 8):viii39Yviii42.
6. Gaffney DK, Du Bois A, Narayan K, et al. Practice patterns of radiotherapy in cervix cancer among member groups of the Gynecologic Cancer Intergroup (GCIG). Int J Radiat Oncol Biol Phys. 2007;68(2): 485-490.
7. Small W, Du Bois A, Narayan K, et al. Practice patterns of radiotherapy in endometrial cancer among member groups of the Gynecologic Cancer Intergroup (GCIG). Int J of Gynecol Cancer. 2006;16(3):812.
8. Boronow RC. Therapeutic alternative to primary exenteration for advanced vulvovaginal cancer. Gynecol Oncol. 1973;100(1):233-255.
9. Boronow RC. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer: rationale and results. Cancer. 1982;10(49):1085-1091.
10. Moore DH, Thomas GM, Montana GS, et al. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys. 1998;42(1):79-85.
11. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(Pt 15):1144-1153.
12. Pearcy T, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol. 2002;20(4):966-972.
13. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137-1143.
14. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of Radiation Therapy Oncology Group trial (RTOG) 90-01. J Clin Oncol. 2004;22(5):872-880.
15. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17(Pt 5): 1339-1348.
16. Peters WA III, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606-1613.
17. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(Pt 15):1154-1161.
18. Haie-Meder C, Fervers B, Fondrinier E, et al. SOR guidelines for concomitant chemoradiotherapy for patients with uterine cervical cancers: evidence update bulletin 2004. Ann Oncol. 2005;16(7): 1100-1108.
19. Barbera L, Paszat L, Thomas G, et al. The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation. Int J Radiat Oncol Biol Phys. 2006;64(5):1389-1394.
20. Lanciano RM, Pajak TF, Martz K, et al. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Biol Phys. 1993;25(3):391-397.
21. Komaki R, Brickner TJ, Hanlon AL, et al. Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983: Patterns of Care Study (PCS). Int J Radiat Biol Phys. 1995;31(4):973-982.
22. Eifel PJ, Moughan J, Erickson B, et al. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a pattern of care study. Int J Radiat Biol Phys 2004;60(4):1144-1153.
23. Teshima T. Patterns of care study in Japan. Jpn J Clin Oncol. 2005;35(9):497-506.
24. Erickson B, Eifel P, Moughan J, et al. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a pattern of care study. Int J Radiat Oncol Biol Phys. 2005;63(4): 1083-1092.
25. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet. 2001; 358(9284):781-786.
26. Vlastos AT, Usel M, Beffa V, et al. Treatment patterns of vulvar cancer in the elderly. Surg Oncol. 2004;13(4):187-191.
27. Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer. 2000;89(1):116-122.
28. Lataifeh I, Nascimento MC, Nicklin JL, et al. Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol. 2004;95(3):701-705.
29. Woolderink JM, de Bock GH, de Hullu JA, et al. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol. 2006;103(1):293-299.
30. Gonzalez Bosquet J, Magrina JF, Magtibay PM, et al. Patterns of inguinal groin metastases in squamous cell carcinoma of the vulva. Gynecol Oncol. 2007;105(3):742-746.
31. Levenback C, Morris M, Burke TW, et al. Groin dissection practices among gynecologic oncologists treating early vulvar cancer. Gynecol Oncol. 1996;62(1):73-77.
32. du Bois A, Rochon J, Lamparter C, et al. Pattern of care and impact of participation in clinical trials on outcome in ovarian cancer. Int J Gynecol Cancer. 2005;15:183-191.